» Articles » PMID: 22984509

Apolipoprotein E4 is Deficient in Inducing Macrophage ABCA1 Expression and Stimulating the Sp1 Signaling Pathway

Overview
Journal PLoS One
Date 2012 Sep 18
PMID 22984509
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

ATP binding cassette A1 (ABCA1) is a membrane protein that promotes cellular cholesterol efflux. Using RAW 264.7 macrophages, we studied the relative effects of apolipoprotein (apo) E3 and apoE4 on ABCA1 and on the signaling pathway that regulates its expression. Both lipid-associated and lipid-free apoE4 forms induced ~30% lower levels of ABCA1 protein and mRNA than apoE3 forms. Phosphorylated levels of phosphoinositol 3-kinase (PI3K), protein kinase Cζ (PKCζ) and specificity protein 1 (Sp1) were also lower when treated with apoE4 compared to apoE3. The reduced ability of apoE4 to induce ABCA1 expression, PKCζ and Sp1 phosphorylation were confirmed in human THP-1 monocytes/macrophages. Sequential phosphorylation of PI3K, PKCζ and Sp1 has been suggested as a mechanism for upregulation of ABCA1 expression. Both apoE3 and apoE4 reduced total cholesterol and cholesterol esters in lipid-laden RAW 264.7 cells, and induced apoAI-mediated cholesterol efflux. However, the cholesterol esters and cholesterol efflux in apoE4-treated cells were ~50% and ~24% lower, respectively, compared to apoE3-treated cells. Accumulation of cholesterol esters in macrophages is a mechanism for foam cell formation. Thus the reduced ability of apoE4 to activate the PI3K-PKCζ-Sp1 signaling pathway and induce ABCA1 expression likely impairs cholesterol ester removal, and increases foam cell formation.

Citing Articles

Genes Differentially Expressed Across Major Arteries Are Enriched in Endothelial Dysfunction-Related Gene Sets: Implications for Relative Inter-artery Atherosclerosis Risk.

Brown P Bioinform Biol Insights. 2024; 18:11779322241251563.

PMID: 38765020 PMC: 11100403. DOI: 10.1177/11779322241251563.


Apolipoprotein E and viral infection: Risks and Mechanisms.

Chen F, Ke Q, Wei W, Cui L, Wang Y Mol Ther Nucleic Acids. 2023; 33:529-542.

PMID: 37588688 PMC: 10425688. DOI: 10.1016/j.omtn.2023.07.031.


Apolipoprotein E in Cardiometabolic and Neurological Health and Diseases.

Alagarsamy J, Jaeschke A, Hui D Int J Mol Sci. 2022; 23(17).

PMID: 36077289 PMC: 9456500. DOI: 10.3390/ijms23179892.


Glycosylation of HDL-Associated Proteins and Its Implications in Cardiovascular Disease Diagnosis, Metabolism and Function.

Romo E, Zivkovic A Front Cardiovasc Med. 2022; 9:928566.

PMID: 35694676 PMC: 9184513. DOI: 10.3389/fcvm.2022.928566.


A multi-hit hypothesis for an APOE4-dependent pathophysiological state.

Steele O, Stuart A, Minkley L, Shaw K, Bonnar O, Anderle S Eur J Neurosci. 2022; 56(9):5476-5515.

PMID: 35510513 PMC: 9796338. DOI: 10.1111/ejn.15685.


References
1.
Mazzone T, GUMP H, Diller P, Getz G . Macrophage free cholesterol content regulates apolipoprotein E synthesis. J Biol Chem. 1987; 262(24):11657-62. View

2.
Chen W, Sun Y, Welch C, Gorelik A, Leventhal A, Tabas I . Preferential ATP-binding cassette transporter A1-mediated cholesterol efflux from late endosomes/lysosomes. J Biol Chem. 2001; 276(47):43564-9. DOI: 10.1074/jbc.M107938200. View

3.
Yamamoto T, Ryan R . Anionic phospholipids inhibit apolipoprotein E--low-density lipoprotein receptor interactions. Biochem Biophys Res Commun. 2007; 354(3):820-4. DOI: 10.1016/j.bbrc.2007.01.066. View

4.
Blacklow S . Versatility in ligand recognition by LDL receptor family proteins: advances and frontiers. Curr Opin Struct Biol. 2007; 17(4):419-26. PMC: 2766800. DOI: 10.1016/j.sbi.2007.08.017. View

5.
Mahley R, Innerarity T, Rall Jr S, Weisgraber K . Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res. 1984; 25(12):1277-94. View